Eric K. Nicholson

Array ( [id] => 8830091 [patent_doc_number] => 20130131136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'NOVEL METHODS FOR PREDICTING THE RESPONSIVENESS OF A PATIENT AFFECTED WITH A TUMOR TO A TREATMENT WITH A TYROSINE KINASE INHIBITOR' [patent_app_type] => utility [patent_app_number] => 13/812932 [patent_app_country] => US [patent_app_date] => 2011-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6774 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13812932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10058377 [patent_doc_number] => 09097729 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-04 [patent_title] => 'Methods of selecting epidermal growth factor receptor (EGFr) binding agents' [patent_app_type] => utility [patent_app_number] => 13/191227 [patent_app_country] => US [patent_app_date] => 2011-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15359 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13191227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11226130 [patent_doc_number] => 09453847 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-27 [patent_title] => 'Mannose receptor C type 1 (MRC1) codon optimized cell line and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/811122 [patent_app_country] => US [patent_app_date] => 2011-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 24 [patent_no_of_words] => 12369 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8842228 [patent_doc_number] => 20130137856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/810657 [patent_app_country] => US [patent_app_date] => 2011-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 40776 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8927527 [patent_doc_number] => 20130183287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-18 [patent_title] => 'PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/810652 [patent_app_country] => US [patent_app_date] => 2011-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 40777 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742321 [patent_doc_number] => 20120020988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'Antibodies specifically binding to human TSLPR and methods of use' [patent_app_type] => utility [patent_app_number] => 13/184046 [patent_app_country] => US [patent_app_date] => 2011-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13084 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20120020988.pdf [firstpage_image] =>[orig_patent_app_number] => 13184046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8955406 [patent_doc_number] => 08501176 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-06 [patent_title] => 'Methods of reducing eosinophil levels' [patent_app_type] => utility [patent_app_number] => 13/177221 [patent_app_country] => US [patent_app_date] => 2011-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 48 [patent_no_of_words] => 33174 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13177221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8585690 [patent_doc_number] => 20130004511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'COMPOSITION COMPRISING INHIBITORS OF IRS-1 AND OF VEGF' [patent_app_type] => utility [patent_app_number] => 13/174038 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11134 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13174038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10090239 [patent_doc_number] => 09127052 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-08 [patent_title] => 'LLT-1 antibodies with new functional properties' [patent_app_type] => utility [patent_app_number] => 13/807505 [patent_app_country] => US [patent_app_date] => 2011-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 11 [patent_no_of_words] => 22927 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13807505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580815 [patent_doc_number] => 20110294698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'PROCESS FOR IDENTIFYING DRUGS FOR TREATING GASTROESOPHAGEAL REFLUX' [patent_app_type] => utility [patent_app_number] => 13/165133 [patent_app_country] => US [patent_app_date] => 2011-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 22562 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294698.pdf [firstpage_image] =>[orig_patent_app_number] => 13165133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9449385 [patent_doc_number] => 20140120555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-01 [patent_title] => 'ANTI-CXCR4 ANTIBODY WITH EFFECTOR FUNCTIONS AND ITS USE FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/126944 [patent_app_country] => US [patent_app_date] => 2011-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 24757 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14126944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8066037 [patent_doc_number] => 20110244005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'CONTROLLED RELEASE CGRP DELIVERY COMPOSITION FOR CARDIOVASCULAR AND RENAL INDICATIONS' [patent_app_type] => utility [patent_app_number] => 13/162285 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18482 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20110244005.pdf [firstpage_image] =>[orig_patent_app_number] => 13162285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10514982 [patent_doc_number] => 09242014 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-26 [patent_title] => 'Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment conjugates and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/703864 [patent_app_country] => US [patent_app_date] => 2011-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 22 [patent_no_of_words] => 12258 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13703864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817446 [patent_doc_number] => 20120064066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'Monoclonal Antibodies to Hepatocyte Growth Factor' [patent_app_type] => utility [patent_app_number] => 13/160444 [patent_app_country] => US [patent_app_date] => 2011-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10808 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064066.pdf [firstpage_image] =>[orig_patent_app_number] => 13160444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8270168 [patent_doc_number] => 08211670 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Production and purification of IL-29' [patent_app_type] => utility [patent_app_number] => 13/114566 [patent_app_country] => US [patent_app_date] => 2011-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36791 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13114566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8684379 [patent_doc_number] => 20130052663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'Chimeric Receptors and Methods for Identifying Agents Exhibiting an Activity on Type 1 Single Pass Transmembrane Receptors' [patent_app_type] => utility [patent_app_number] => 13/695654 [patent_app_country] => US [patent_app_date] => 2011-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 22494 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7776399 [patent_doc_number] => 20120039924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE' [patent_app_type] => utility [patent_app_number] => 13/092888 [patent_app_country] => US [patent_app_date] => 2011-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 41661 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039924.pdf [firstpage_image] =>[orig_patent_app_number] => 13092888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7579716 [patent_doc_number] => 20110293599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'METHOD FOR MODULATING MUSCLE DIFFERENTIATION OR REGENERATION' [patent_app_type] => utility [patent_app_number] => 13/086593 [patent_app_country] => US [patent_app_date] => 2011-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 8418 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293599.pdf [firstpage_image] =>[orig_patent_app_number] => 13086593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8801916 [patent_doc_number] => 08440188 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-14 [patent_title] => 'Therapeutic and diagnostic anti-HSP70 antibodies' [patent_app_type] => utility [patent_app_number] => 13/081015 [patent_app_country] => US [patent_app_date] => 2011-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 13 [patent_no_of_words] => 30520 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13081015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9421171 [patent_doc_number] => 20140105821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-17 [patent_title] => 'ANTIBODY THAT STOPS OR SLOWS TUMOUR GROWTH (VARIANTS)' [patent_app_type] => utility [patent_app_number] => 13/982518 [patent_app_country] => US [patent_app_date] => 2011-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7055 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13982518 [rel_patent_id] =>[rel_patent_doc_number] =>)